In 2025, WHO published an executive summary on climate change and health, opening with a bold statement: “Climate change is arguably the greatest health threat of the 21st century.”
Although typical news headlines are dominated by extreme weather events, acknowledgement of the climate’s impact on skin rarely enters the conversation. In our opinion, it should.
As global temperatures climb and severe storms, flooding and wildfires affect a larger share of the population, we must remember that skin is our largest organ and constantly interfaces with our environment.

Many skin diseases are climate

Preservative-free latanoprost improved IOP as effectively as preserved latanoprost while improving ocular safety among patients with glaucoma and ocular hypertension, according to a study published in Journal of Glaucoma.
“Our findings support preservative-free latanoprost as an effective first-line option for lowering intraocular pressure, especially for patients with ocular surface disease, dry eye symptoms, preservative intolerance or those expected to require long-term topical therapy,” Hashem Abu Serhan, MD, FICO, FIOF, of the department of ophthalmology at Hamad Medical Corp. in Doha,

KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of treating keratoconus with additive keratoplasty.
“Whether that’s CTAK or CAIRS, we now have a fairly noninvasive surgical way, especially compared with corneal transplantation, to help patients improve their vision, whether it’s uncorrected visual acuity, spectacle corrected visual acuity or less dependence on scleral lenses,” Meghpara, of Wills Eye Hospital, said.

Black Americans continue to have higher rates of heart disease mortality compared with white Americans, despite a decline in recent years, according to data from a Journal of the American College of Cardiology progress report.
“After 2.5 decades of follow-up, the gap in excess cardiovascular mortality for Black compared with white Americans is smaller than it was in 2000 but no smaller than it was a decade ago. The 2024 update shows partial recovery from the pandemic-era widening but no return to the trajectory of modest decline that characterized the early 2000s,” Adith S. Arun, a medical

SEATTLE — Arthroscopic Bankart repair for patients with on-track Hill-Sachs lesions yielded high rates of recurrent instability at minimum 7-year follow-up, according to results presented here.
“Long-term recurrent instability rates were high following isolated Bankart repair for on-track lesions with less than 20% glenoid bone loss and were associated with inferior patient-reported outcomes at final follow-up,” Sahil Dadoo, MD, said in his presentation at the American Orthopaedic Society for Sports Medicine Annual Meeting.
Dadoo, resident physician in the department of orthopedic surgery at

Using a continuous glucose monitor improved time in range with no increase in hypoglycemia for people with type 2 diabetes undergoing hemodialysis for end-stage kidney failure, researchers reported in Diabetes Care.
“Maintaining adequate glycemic control in people with end-stage kidney disease on hemodialysis is challenging,” Rodolfo J. Galindo, MD, associate professor of medicine at University of Miami Miller School of Medicine, told Healio. “We showed that using a minimally invasive device, real-time CGM, for just 30 days improved glycemic metrics in this population.”
Galindo and colleagues

Patients with Parkinson’s disease experienced “significant and clinically meaningful” improvements in motor symptoms over 27 weeks with tavapadon, according to a study published in The Lancet Neurology.
Tavapadon selectively targets D1/D5 receptors with reduced risk for adverse events that emerge with other dopaminergic treatment, Cindy Zadikoff, MD, executive medical director at AbbVie, and colleagues wrote.
“There are many good treatments out there for Parkinson’s disease, but oftentimes patients and physicians are having to make tradeoffs between efficacy, tolerability and safety,” Zadikoff

Editor’s note: This is a developing news story. Please check back soon for updates.
The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in patients with geographic atrophy, has launched commercially across 30 European countries.
According to a press release from Science Corp., the implant is the first brain-computer interface (BCI) device to receive CE marking for vision restoration in dry age-related macular degeneration, with the first commercial implant procedure expected to take place in Germany. The launch is supported by

The 2026 Early Steps to Transplant Access Registry annual report highlighted trends in kidney transplant referrals, evaluations and wait-listing in 13 U.S. states.
The data spanned between 2015 and 2024, including new patients on dialysis from 37 transplant centers in the four major End-Stage Renal Disease Network regions of New England, New York, Ohio River Valley and the Southeast.
Researchers found transplant referral rates within 1 year of starting dialysis increased from 24.3% to 33.4% (2015-2023), evaluation rates within 3 months of referral decreased from 42% to 24.3% (2015-2024) and

Among patients with pulmonary arterial hypertension, once-daily treprostinil palmitil inhalation powder for 12 months was well tolerated and improved four efficacy endpoints, according to interim data from an open-label extension study.
“In everyday practice, clinicians are focused on optimizing therapy to help patients achieve the greatest benefit while maintaining tolerability and safety,” Eugene Sullivan, MD, chief product strategy officer at Insmed, told Healio. “One of the key differentiating features of treprostinil palmitil inhalation powder (TPIP) is the ability to increase the dose